Circulating TERT serves as the novel diagnostic and prognostic biomarker for the resectable NSCLC

Circulating TERT serves as the novel diagnostic and prognostic biomarker for the resectable NSCLC

Abstract Background Telomerase reverse transcriptase (TERT) is a catalytic subunit of telomerase and required for cancer development. This study aims to reveal its clinical utility for diagnosis and prognosis of resectable NSCLC. Methods TERT was quantitatively evaluated by the enzyme-linked immunos...

Full description

Bibliographic Details
Main Authors: Guanxuan Chen, Shiwen Wang, Qianru Zhang, Junyan Liu, Wanqi Zhu, Xianrang Song, Xingguo Song
Format: Article
Language:English
Published: BMC 2024-12-01
Series:Cancer Cell International
Subjects:
Telomerase reverse transcriptase (TERT)
Resectable NSCLC
Prognosis
Diagnosis
Leukocyte telomere length (LTL)
Online Access:https://doi.org/10.1186/s12935-024-03605-w

Internet

https://doi.org/10.1186/s12935-024-03605-w

Similar Items